Skip to main content
logo
Oryzon Genomics S.A. (BME:ORY)
Spain flag Spain · Delayed Price · Currency is EUR
2.820
-0.020 (-0.70%)
Aug 27, 2026, 5:35 PM CET

Oryzon Genomics Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
15.4110.937.3614.1915.710.62
Revenue Growth
106.22%48.59%-48.15%-9.60%47.88%11.49%
Gross Profit
15.0610.657.0613.9515.239.87
Operating Income
-5.94-5.71-4.5-4.56-5.5-7.01
Net Income
-2.43-2.61-3.58-3.35-4.23-4.69
Earnings Per Share
-0.03-0.03-0.06-0.06-0.08-0.09
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
14.6928.375.6212.2621.3228.72
Total Debt
10.817.7616.2118.2722.5417.52
Net Cash (Debt)
3.8910.61-10.59-6.02-1.2211.2
Net Cash Growth
-70.05%-----57.02%
Net Cash Per Share
0.050.14-0.16-0.10-0.020.21

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.91-2.36-5.69-0.57-1.85-3.63
Capital Expenditures
-0.09-0.06-0.1--0.08-0.18
Free Cash Flow
-5-2.42-5.79-0.57-1.92-3.8
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
97.75%97.42%95.89%98.28%97.04%92.97%
Operating Margin
-38.56%-52.25%-61.18%-32.16%-35.02%-66.07%
Pretax Margin
-38.77%-51.20%-74.52%-43.01%-41.77%-67.64%
Profit Margin
-15.76%-23.83%-48.62%-23.63%-26.96%-44.15%
FCF Margin
-32.44%-22.09%-78.70%-4.05%-12.25%-35.82%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-13.98106.87---
PS Ratio
15.0022.4312.318.108.4813.42